- Stock: IN STOCK
- Brand: DEUS MEDICAL
- Reward Points: RECEIVE 4 REWARD POINTS
- Model: MOD GRF 1-29
- Review count: 0 , Add testimonial
- Average rating: 0
Mod GRF 1-29 — research GHRH analogue
Mod GRF 1-29 is a modified growth-hormone-releasing hormone analogue, studied for a stable, targeted GH-axis signal without the long tail of the DAC-modified peptides. Its shorter, cleaner action is why researchers pair it so often with a GHRP for a pulsed response. HelixaMed supplies Mod GRF 1-29 lyophilised and lab-verified for identity and concentration.
As with every peptide, correct handling is essential: freeze-dried on arrival, reconstituted with bacteriostatic water and stored cold. Our guides cover the process so a protocol runs on stable material. This is a research-use compound only; no dosing or human-use instructions are provided.
- Clean GHRH signal: shorter action than the DAC peptides.
- Pulsed pairing: often combined with a GHRP.
- Verified: lyophilised, batch-analysed.
WHAT IS TETRASUBSTITUED 29-AMINO ACID PEPTIDE HORMONE:
Is a term used to identify a 29 amino acid peptide analogue of growth-hormone-releasing hormone (GHRH), a releasing hormone of growth hormone (GH).
It is a modified version of the shortest fully functional fragment of GHRH, often referred to as growth hormone releasing factor (1-29) (abbreviated as GRF (1-29)), and also known by its standardized name, sermorelin.
ALSO KNOWN AS:
Modified GRF
MOD GRF 1-29 DOSAGE:
Tetrasubstitued 29-Amino Acid Peptide Hormone 2mg/vial
PACKAGE CONTENT:
1 Box of 1 Vial
HOW TO USE MOD GRF 1-29:
Inject 100mcg 3 times per day.
It has a synergistic effect with Ipamorelin.